AN2 Therapeutics ANTX
Last Price
52 Week Range
$1.01 - $1.55
Next Earnings Date
Mar 24 2026 (Estimate)
Next Earnings Date
Mar 24 2026 (Est.)
Last Price
ANTX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
AN2 Therapeutics, Inc. | 10-Q | November 12, 2025 | |
AN2 Therapeutics, Inc. | 8-K | November 12, 2025 | |
AN2 Therapeutics, Inc. | 10-Q | August 12, 2025 | |
AN2 Therapeutics, Inc. | 8-K | August 12, 2025 | |
AN2 Therapeutics, Inc. | 8-K | June 20, 2025 | |
AN2 Therapeutics, Inc. | 8-K | June 11, 2025 | |
AN2 Therapeutics, Inc. | 8-K | May 27, 2025 | |
AN2 Therapeutics, Inc. | 10-Q | May 13, 2025 | |
AN2 Therapeutics, Inc. | 8-K | May 13, 2025 | |
AN2 Therapeutics, Inc. | 8-K | May 1, 2025 | |
AN2 Therapeutics, Inc. | ARS | April 11, 2025 | |
AN2 Therapeutics, Inc. | DEFA14A | April 10, 2025 | |
AN2 Therapeutics, Inc. | DEF 14A | April 10, 2025 | |
AN2 Therapeutics, Inc. | 10-K | March 25, 2025 | |
AN2 Therapeutics, Inc. | 8-K | March 25, 2025 | |
AN2 Therapeutics, Inc. | 10-Q | November 13, 2024 | |
AN2 Therapeutics, Inc. | 8-K | November 13, 2024 | |
AN2 Therapeutics, Inc. | 8-K | November 5, 2024 | |
AN2 Therapeutics, Inc. | 8-K | August 19, 2024 | |
AN2 Therapeutics, Inc. | 10-Q | August 13, 2024 | |
AN2 Therapeutics, Inc. | 8-K | August 13, 2024 | |
AN2 Therapeutics, Inc. | 8-K | August 8, 2024 | |
AN2 Therapeutics, Inc. | 8-K | June 24, 2024 | |
AN2 Therapeutics, Inc. | 10-Q | May 14, 2024 | |
AN2 Therapeutics, Inc. | 8-K | May 14, 2024 | |
AN2 Therapeutics, Inc. | ARS | April 26, 2024 | |
AN2 Therapeutics, Inc. | DEFA14A | April 26, 2024 | |
AN2 Therapeutics, Inc. | DEF 14A | April 26, 2024 | |
AN2 Therapeutics, Inc. | PRE 14A | April 5, 2024 | |
AN2 Therapeutics, Inc. | 10-K | March 29, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.